remind
although
term
sepsi
valuabl
clinic
descriptor
condit
almost
everi
doctor
encount
catchal
natur
term
often
conceal
reveal
determin
true
incid
sepsi
underli
caus
import
quantifi
burden
diseas
ensur
adequ
resourc
provid
deal
also
inform
prioriti
clinic
research
howev
use
registri
data
unexpect
pitfal
factor
ascertain
artefact
subtl
chang
defi
nition
better
earlier
diagnosi
even
reimburs
consider
fals
seem
increas
incid
popul
kaukonen
colleagu
publish
analysi
trend
incid
mortal
associ
sepsi
adult
australia
new
zealand
care
avoid
danger
show
data
children
incid
rise
mortal
fall
also
report
signifi
cant
diff
erenc
outcom
depend
age
presenc
comorbid
overal
crude
hospit
mortal
patient
comorbid
compar
patient
younger
year
age
without
underli
complic
data
import
implic
imagin
plan
phase
trial
new
intervent
sepsi
primari
endpoint
hospit
mortal
calcul
number
patient
enrol
would
base
anticip
eff
ect
size
intervent
mortal
rate
placebo
group
studi
popul
contain
subgroup
much
lower
expect
mortal
calcul
would
wrong
mortal
placebo
group
would
lower
true
eff
ect
intervent
might
miss
type
error
possibl
concern
mani
peopl
studi
sepsi
furthermor
use
broad
enrol
criteria
investig
might
includ
mix
popul
might
respons
intervent
therebi
lower
signaltonois
ratio
point
potenti
valuabl
treatment
identifi
ed
possibl
reason
accur
inform
incid
sever
sepsi
children
adult
import
also
research
care
describ
exactli
patient
talk
interpret
data
although
sepsi
instantli
recognis
although
sadli
alway
instantli
mani
investig
creasingli
uneasi
use
basi
clinic
trial
schlapbach
colleagu
provid
valuabl
data
show
sepsi
children
remain
signifi
cant
challeng
discard
term
sepsi
would
wise
paradox
meet
challeng
might
mean
research
longer
use
sepsi
start
point
clinic
research
diffi
cult
frustrat
fi
eld
lancet
infecti
diseas
patricia
schlagenhauf
colleagu
analys
travelassoci
morbid
travel
present
european
site
geosentinel
network
posttravel
ill
period
knowledg
ill
travel
contribut
understand
diseas
epidemiolog
interconnect
world
addit
ill
health
travel
serv
sentinel
infecti
diseas
moreov
also
transmit
dissemin
infect
travel
shown
import
role
emerg
infect
sar
sever
acut
respiratori
syndrom
dengu
viru
infect
chikungunya
infect
current
ebola
viru
diseas
also
antibiot
resist
geosentinel
surveil
network
collabor
intern
societi
travel
medicin
us
center
diseas
control
prevent
describ
signifi
cant
diseas
epidemiolog
travel
also
identifi
ed
emerg
infect
travel
sarcocysti
tioman
island
ongo
dengu
outbreak
luanda
angola
strength
geosentinel
data
includ
eurotravnet
data
analys
schlagenhauf
colleagu
larg
number
report
case
diff
erent
part
world
weak
howev
mainli
descript
variat
diseas
pattern
year
might
attribut
evolv
travel
pattern
includ
chang
destin
itinerari
thu
shift
diseas
trend
inter
prete
caution
might
simpli
relat
chang
exposur
moreov
diseas
eg
dengu
fever
also
occur
countri
report
geosentinel
simpli
tourist
destin
even
inher
shortcom
dataset
fi
nding
tuberculosi
transmiss
within
europ
remain
problem
dengu
transmiss
occur
europ
provid
new
valuabl
insight
transmiss
dynam
infect
analysi
subgroup
addit
strength
studi
show
reduc
rate
malaria
hiv
hepat
type
travel
receiv
pretravel
advic
author
identifi
ed
travel
subsaharan
africa
asia
signifi
cantli
associ
acquisit
travelrel
ill
data
immigr
travel
also
show
increas
acquisit
travel
africa
interestingli
trend
time
show
increas
proportion
morbid
vectorborn
diseas
particularli
malaria
dengu
author
show
associ
dengu
viru
certain
destin
countri
origin
highlight
popular
destin
variou
nation
previou
analysi
dengu
geosentinel
network
detect
increas
trend
travel
nation
outbreak
trend
came
public
recognit
detail
inform
provid
author
might
help
nation
health
author
formul
optimum
advic
travel
pattern
diseas
shown
european
site
relat
global
diseas
outbreakseg
predomin
infl
uenza
pandem
among
respiratori
infect
anoth
relev
time
exampl
chikungunya
emerg
island
countri
indian
ocean
includ
comoro
reunion
subsequ
aff
ect
india
sri
lanka
maldiv
southeast
asia
recent
america
pacifi
c
island
eurotravnet
data
parallel
develop
local
aff
ect
show
util
travel
sentinel
emerg
infect
chikungunya
fi
rst
document
caribbean
decemb
travel
exposur
america
would
includ
report
schlagenhauf
colleagu
importantli
associ
pretravel
consult
signifi
cantli
reduc
proportion
morbid
plasmodium
falciparum
hiv
aid
valid
goal
travel
medicin
practic
fi
nding
smaller
proport
travel
visit
friend
rel
obtain
pretravel
advic
compar
tourist
travel
support
polici
aim
improv
provis
pretravel
intervent
travel
visit
friend
rel
despit
merit
fi
nal
challeng
remain
analysi
deriv
actual
risk
acquir
travelrel
infect
view
method
sampl
consortium
travel
tropic
medicin
centr
lack
denominatorthat
popul
risk
nevertheless
report
european
travel
provid
valuabl
inform
associ
ill
travel
subsaharan
africa
asia
potenti
acquir
endem
infect
even
travel
part
europ
increas
report
vectorborn
infect
time
role
travel
sentinel
dissemin
infect
fi
nalli
benefi
ts
pretravel
health
prepar
fi
nding
contribut
creation
target
pretravel
advic
particular
diseas
popul
destin
men
sex
men
msm
substanti
burden
diseas
associ
human
papillomaviru
hpv
infect
includ
anogenit
wart
anal
cancer
penil
cancer
oropharyng
cancer
howev
dynam
hpv
transmiss
young
msm
poorli
understood
understand
natur
histori
hpv
infect
men
becom
increasingli
import
polici
countri
consid
adopt
sexneutr
hpv
vaccin
programm
lancet
infecti
diseas
huachun
zou
colleagu
report
high
incid
hpv
infect
australian
adolesc
young
msm
age
year
median
age
year
year
followup
period
detect
incid
defi
nite
hpv
infect
anu
ten
incid
defi
nite
hpv
infect
peni
defi
nite
incid
rate
per
personyear
anal
hpv
infect
ci
penil
hpv
infect
author
estim
per
partner
transmiss
comparison
data
studi
goldston
colleagu
report
higher
probabl
peni
anu
anu
peni
transmiss
estim
best
adolesc
msm
best
data
popul
time
soon
data
report
best
seen
rough
estim
albeit
good
one
view
mani
diff
erenc
two
sampl
import
other
cite
use
data
keep
limit
mind
first
estim
partner
incid
goldston
colleagu
somewhat
older
sampl
msm
use
zhou
colleagu
half
zou
colleagu
sampl
report
older
sexual
partner
furthermor
although
entir
sampl
use
zou
colleagu
australia
goldston
sampl
australia
markedli
lower
preval
hpv
infect
compar
rest
studi
sampl
second
transmiss
estim
account
penil
penil
transfer
hpv
frottag
third
year
separ
collect
data
two
studi
diff
erenc
could
bia
estim
somewhat
higher
lower
true
rate
despit
potenti
limit
zou
colleagu
note
data
novel
valuabl
hpv
transmiss
estim
use
mani
reason
includ
increas
precis
hpv
vaccin
costeff
ectiv
model
zou
colleagu
fi
nding
inform
polici
decis
sever
countri
debat
routin
provis
hpv
vaccin
boy
men
hpv
vaccin
programm
target
young
msm
appeal
higher
risk
hpvrelat
diseas
young
men
thu
especi
like
receiv
benefi
vaccin
howev
evid
suggest
riskbas
vaccin
strategi
success
exampl
usa
abandon
riskbas
vaccin
nation
eff
ort
give
hepat
b
vaccin
msm
declar
compet
interest
